Pushpa Bhakuni Negi

Dr. Pushpa Bhakuni Negi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Food Science and Biotechnology
Verified
Journal Article
Closed access
PDF file
NJNaveen Chandra Joshi
Naveen Chandra Joshi
PNPushpa Bhakuni Negi
Pushpa Bhakuni Negi
PGPrateek Gururani
Prateek Gururani

8 April 2020
Verified
Book Chapter
Open access
PDF file
NKNeha Karki
Neha Karki
ARAnita Rana
Anita Rana
HTHimani Tiwari
Himani Tiwari
PNPushpa Bhakuni Negi
Pushpa Bhakuni Negi
NSNanda Gopal Sahoo
Nanda Gopal Sahoo
Recent advancements in graphene-based nanomaterials provide the opportunity that compliments the limitations of conventional drug delivery systems (DDSs) through simultaneous targeting of the anticancer drug to the cancer cell by reducing the side effects of other administration routes. Graphene with its extraordinary electronic properties like larger surface area, possibilities of surface modification, can efficiently target the tumor cell. At the same time, nanocarriers have the advantages of immune clearance adulteration of physicochemical properties of anticancer drug. The DDSs can be made by biodegradable nanocarriers such as proteins, peptides, biocompatible polymers, antibodies, polymer-drug conjugates, etc. Graphene-supported DDSs in cancer therapy also supports the co-delivery of therapeutic agents, antioxidants, SiRNA, shRNA, etc. as the co-delivery approach, which provide additive or synergistic therapeutic efficacy and can reduce toxic effects.